Post Offer Free
Wuhan Yuancheng Gongchuang Technology Co,ltd
Wuhan Yuancheng Gongchuang Technology Co,ltd

China PRL-8-53 HCL Improve Memory CAS 51352-87-5 Nootropic Raw Powder manufacturer

2nd

Gold Index: 167643

You are here: home  > Pharmaceutical raw material  > Other pharmaceuticals  > PRL-8-53 HCL Improve Memory CAS 51352-87-5 Nootropic Raw Powder

PRL-8-53 HCL Improve Memory CAS 51352-87-5 Nootropic Raw Powder 

Qty (Other,ml) Unit Price (160.0~290.0 USD)
100 - 199 160
200 + 290
Payment Terms: T/T,WU,Money Gram;bitcoin 
Place of Origin: Hubei, China (Mainland) 
inquire skype
Add to My Favorites
HiSupplier Escrow
Share |

Product Detail

Model No.: hkyc
Production Capacity: 100000L/WEEK
Delivery Date: with 6 working hours
service: resend guarantee
Supply Ability: Mass Stock
Model Number: 51352-87-5
Usage: Pharmaceutical Raw
Shipping: 3-7 Days / Door-to-Door
Means of Transport: Air
Packing: brand new
package: Special disguised packaging...
Payment Terms: Western Union, MoneyGram, B...
Certification: ISO
Active-Life: 7-9 days
Lead Time: Within 12 Hours After Payme...

Nootropic Raw Powder PRL-8-53 HCL Improve Memory CAS 51352-87-5
Nootropic Raw Powder PRL-8-53 HCL Improve Memory CAS 51352-87-5
Nootropic Raw Powder

Name:PRL-8-53
Chemical name:Methyl 3-(2-(benzyl(methyl)amino)ethyl)benzoate
Synonyms:PRL-8053;PRL-8-53;Methyl 3-(2-(benzyl(Methyl)aMino)ethyl)benzoate hydrochloride;3-(2-Benzyl(methyl)aminoethyl)benzoic acid methyl ester hydrochloride;m-[2-(Benzylmethylamino)ethyl]benzoic acid methyl ester hydrochloride;Benzoic acid, 3-(2-(Methyl(phenylMethyl)aMino)ethyl)-, Methyl ester, hydrochloride
CAS 51352-87-5
MF:C18H22ClNO2
MW 319.82578


Dosage:
Subjects in human trials have been given up to 100 mg a day and did not appear to develop any negative side effects

 

Abstract
The effect of 3-(2-benzylmethylaminoethyl) benzoic acid methyl ester hydrochloride (PRL-8-53) on learning and on retention of verbal information in human subjects was investigated. Using the serial anticipation method under double-blind conditions it was found that PRL-8-53 causes slight improvement of acquisition. Retinetion of verbal information was found improved to a statistically significant degree (most P values better than 0.01, some better than 0.001). No significant changes were found for either visual reaction time or motor control after drug when compared with placebo values.

 

Description
PRL-8-53 (chemical name Methyl 3-(2-(benzyl(methyl)amino)ethyl)benzoate) is a synthetic nootropic compound discovered in 1972 and patented in 1975 by the late Dr. Nikolaus Hansl, a neuropharmacologist at Creighton University in Omaha, Nebraska. Preliminary animal tests indicated that the compound was both safe and significantly nootropic, boosting avoidance learning in rodents with no adverse effects. But the real interest in PRL-8-53 was sparked by a 1978 study on human volunteers, which showed that a single dose of the compound could improve word retention scores by more than 200%.

 

HOW IT WORKS
PRL-8-53's exact mechanisms of action are not well understood, but it is generally believed to regulate the brain's production of and response to several crucial neurotransmitters. In his reports on human and animal studies Hansl indicated that PRL-8-53 potentiates dopamine, partially restricts production of serotonin, and enhances the brain's response to acetylcholine.

Though Hansl's research report on the 1978 human study suggests those actions, it does not clearly delineate the mechanism of action.The fact that older subjects saw the most nootropic benefit from taking the drug supports the concept that dopamine modulation plays a major role in PLR-8-53's effects. Up-regulating the normal age-related lessening of dopamine production that is associated with cognitive decline could have a significant positive impact on both learning and memory.

 

Dosage
The only human study on PRL-8-53 was based on the ingestion of a single 5 mg dose. There is no data on the effectiveness or potential toxicity of any other dosage in humans.

SIDE EFFECTS
No adverse effects from a single 5 mg dose of PRL-8-53 were observed in the human study. Animal studies suggest that the compound has a high therapeutic threshold, but evidence is very limited because no comprehensive toxicity studies have been completed.

 

 

Nootropic Raw Powders
NameCas no.
SunifiramCAS: 314728-85-3
PirespaCAS: 53179-13-8
AdrafinilsCAS: 63547-13-7
Coluracetam(MKC 231)CAS: 135463-81-9
NoopeptCAS: 157115-85-0
PiracetamCAS:7491-74-9
IdebenoneCAS:58186-27-9
CarphedonCAS:77472-70-9
PramiracetamCAS:68497-62-1
RivastigmineCAS:123441-03-2
OxiracetamCAS:62613-82-5
AniracetamCAS:72432-10-1
DonepezilCAS:120014-06-4
Rivastigmine tartrateCAS:129101-54-8
Alpha GPCCAS:28319-77-9
CRL-40,941(Fladrafinil)CAS:90212-80-9
FasoracetamCAS:110958-19-5
GalantamineCAS:1953-04-4
9-fluorenolCAS:1689-64-1
NSI-189 free baseCAS:1270138-40-3
NSI-189 phosphateCAS:1270138-41-4
PhenibutCAS:1078-21-3
PicamilonCAS:62936-56-5
PRL-8-53CAS:51352-87-5
Tianeptine sodiumCAS:30123-17-2
VinpocetineCAS:42971-09-5
VincamineCAS:1617-90-9

 

 

 


Ms. Gina
skype Ms. Gina
Manager
Tel: 86-27-88211875
Mobile: 188 7222 0799
Contact to this supplier

Didn't find what you're looking for? Post Buying Lead or contact HiSupplier Customer Service Center  for help!

Related Search

Find more related products in following catalogs on Hisupplier.com

Other products from this supplier

Company Info

Wuhan Yuancheng Gongchuang Technology Co,ltd [China (Mainland)]


Business Type:Manufacturer, Trading Company
City: Wuhan
Province/State: Hubei
Country/Region: China (Mainland)

Follow Us: Follow us on facebook Follow us on linkedin Follow us on Twitter

Gina:   skype
Service:   skype

You May Like: